TW200640854A - Methods of making pravastatin sodium - Google Patents
Methods of making pravastatin sodiumInfo
- Publication number
- TW200640854A TW200640854A TW095104350A TW95104350A TW200640854A TW 200640854 A TW200640854 A TW 200640854A TW 095104350 A TW095104350 A TW 095104350A TW 95104350 A TW95104350 A TW 95104350A TW 200640854 A TW200640854 A TW 200640854A
- Authority
- TW
- Taiwan
- Prior art keywords
- methods
- pravastatin sodium
- making
- theta
- degrees
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/33—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with hydroxy compounds having more than three hydroxy groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65173805P | 2005-02-09 | 2005-02-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200640854A true TW200640854A (en) | 2006-12-01 |
Family
ID=36499320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095104350A TW200640854A (en) | 2005-02-09 | 2006-02-09 | Methods of making pravastatin sodium |
Country Status (9)
Country | Link |
---|---|
US (1) | US20060194984A1 (zh) |
EP (1) | EP1833780A1 (zh) |
JP (1) | JP2007533663A (zh) |
CN (1) | CN101115706A (zh) |
CA (1) | CA2595635A1 (zh) |
IL (1) | IL183378A0 (zh) |
MX (1) | MX2007009229A (zh) |
TW (1) | TW200640854A (zh) |
WO (1) | WO2006086680A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090076148A1 (en) * | 2007-09-14 | 2009-03-19 | Protia, Llc | Deuterium-enriched pravastatin |
CN101648867B (zh) * | 2009-09-04 | 2012-07-11 | 天津大学 | 一种普伐他汀钠晶型及其制备方法和应用 |
CN105949062B (zh) * | 2016-06-24 | 2017-06-13 | 广东蓝宝制药有限公司 | 一种规模化制备普伐他汀钠d型晶体的工艺 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4319039A (en) * | 1979-06-15 | 1982-03-09 | Merck & Co., Inc. | Preparation of ammonium salt of hypocholesteremic fermentation product |
MX7065E (es) * | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
EP0215665B1 (en) * | 1985-09-13 | 1991-11-21 | Sankyo Company Limited | Hydroxy-ml-236b derivatives, their preparation and use |
US4857547A (en) * | 1988-01-07 | 1989-08-15 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
US4857522A (en) * | 1988-03-21 | 1989-08-15 | E. R. Squibb & Sons, Inc. | Derivatives of pravastatin for inhibiting cholesterol biosynthesis |
US5180589A (en) * | 1988-03-31 | 1993-01-19 | E. R. Squibb & Sons, Inc. | Pravastatin pharmaceuatical compositions having good stability |
US5099035A (en) * | 1989-02-27 | 1992-03-24 | E. R. Squibb & Sons, Inc. | Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same |
US5140012A (en) * | 1990-05-31 | 1992-08-18 | E. R. Squibb & Sons, Inc. | Method for preventing onset of restenosis after angioplasty employing pravastatin |
US5157025A (en) * | 1991-04-01 | 1992-10-20 | E. R. Squibb & Sons, Inc. | Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug |
SI9300303A (en) * | 1993-06-08 | 1994-12-31 | Krka Tovarna Zdravil | Process for isolation of hypolipemic effective substance |
US5942423A (en) * | 1995-06-07 | 1999-08-24 | Massachusetts Institute Of Technology | Conversion of compactin to pravastatin by actinomadura |
US5616595A (en) * | 1995-06-07 | 1997-04-01 | Abbott Laboratories | Process for recovering water insoluble compounds from a fermentation broth |
US5883109A (en) * | 1996-07-24 | 1999-03-16 | Bristol-Myers Squibb Company | Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug |
KR100210482B1 (ko) * | 1997-04-10 | 1999-07-15 | 김종인 | 스트렙토마이세스엑스포리아투스(streptomycesexfoliatus)yj-118과이를이용한프라바스타틴나트륨의제조방법 |
SI20305A (sl) * | 1999-08-06 | 2001-02-28 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Kristali natrijeve soli pravastatina |
US6682913B1 (en) * | 1999-02-03 | 2004-01-27 | Institute For Drug Research Ltd. | Microbial process for preparing pravastatin |
MXPA02005283A (es) * | 1999-11-30 | 2003-10-06 | Biogal Gyogyszergyar | Proceso para recuperar compuestos estatina de un caldo de fermentacion. |
PL364929A1 (en) * | 1999-12-14 | 2004-12-27 | Biogal Gyogyszergyar Rt. | Novel forms of pravastatin sodium |
-
2006
- 2006-02-09 EP EP06734802A patent/EP1833780A1/en not_active Withdrawn
- 2006-02-09 CA CA002595635A patent/CA2595635A1/en not_active Abandoned
- 2006-02-09 WO PCT/US2006/004822 patent/WO2006086680A1/en active Application Filing
- 2006-02-09 JP JP2007507584A patent/JP2007533663A/ja active Pending
- 2006-02-09 US US11/351,468 patent/US20060194984A1/en not_active Abandoned
- 2006-02-09 TW TW095104350A patent/TW200640854A/zh unknown
- 2006-02-09 MX MX2007009229A patent/MX2007009229A/es unknown
- 2006-02-09 CN CNA2006800044588A patent/CN101115706A/zh active Pending
-
2007
- 2007-05-24 IL IL183378A patent/IL183378A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20060194984A1 (en) | 2006-08-31 |
MX2007009229A (es) | 2007-09-25 |
JP2007533663A (ja) | 2007-11-22 |
WO2006086680A1 (en) | 2006-08-17 |
EP1833780A1 (en) | 2007-09-19 |
CN101115706A (zh) | 2008-01-30 |
IL183378A0 (en) | 2007-09-20 |
CA2595635A1 (en) | 2006-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY139902A (en) | Crystalline form v of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
GEP20094577B (en) | New crystalline form iv of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
MX2008008298A (es) | Sal de sulfato de hidrogeno novedosa. | |
GEP20094576B (en) | New cyrstalline form iii of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
UA97478C2 (ru) | Кристаллическая форма vi агомелатина, способ ее приготовления (варианты) и фармацевтическая композиция, которая ее содержит | |
PL1891004T3 (pl) | Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych | |
RS54568B1 (en) | POLYMORPHIC FORMS OF RIFAXIMIN, PROCEDURES FOR ITS MANUFACTURE AND ITS USE IN MEDICINAL PRODUCTS | |
UA94833C2 (en) | Substituted bicyclolactams | |
IL195341A0 (en) | Methods and materials for making simvastatin and related compounds | |
MX346318B (es) | Cristales. | |
ATE495747T1 (de) | Kristalline form des ibandronat-natriums und herstellungsverfahren dafür | |
MX2012007375A (es) | 3-ceto-n-propargil 1-aminoindano. | |
UA100476C2 (en) | New crystalline form vi of agomelatine, preparation method and application thereof | |
TW200728310A (en) | Process for the preparation of ferri-succinylcasein | |
HRP20110641T1 (en) | Crystalline modification of fipronil | |
MX2007010143A (es) | Formas cristalinas de intermedio de linezolid. | |
IN2012DN05209A (zh) | ||
TW200420541A (en) | Crystalline forms | |
RS53057B (en) | NEW CRYSTAL FORM 3- (difluoromethyl) -1-methyl-N- (3`, 4`, 5`-trifluoro [1,1`-biphenyl] -2-yl) -1H-pyrazole-4-carboxamide | |
TW200637832A (en) | Process for preparing amorphous valsartan | |
MX2009005542A (es) | Polvo metalico. | |
MX2010005809A (es) | Proceso de dehidrohalogenacion para la preparacion de intermediarios utiles en el suministro de compuestos 6,6-dimetil-3-azabiciclo-[3,1,0]-hexano. | |
WO2009049382A3 (fr) | Hydroxyde de calcium et / ou de magnesium a tres haute reactivite et sa preparation | |
TW200640854A (en) | Methods of making pravastatin sodium | |
SA114350792B1 (ar) | شكل متبلر جديد من ملح الـبيميرولاست |